Comments
Loading...
Exicure (NASDAQ:XCUR) Stock Quotes, Forecast and News Summary
Exicure Stock (NASDAQ: XCUR) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Exicure (XCUR) stock?
You can purchase shares of Exicure (NASDAQ:XCUR) through any online brokerage.
Who are Exicure (XCUR) competitors?
Other companies in Exicure’s space includes: Acurx Pharmaceuticals (NASDAQ:ACXP), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX), GlycoMimetics (NASDAQ:GLYC) and Longeveron (NASDAQ:LGVN).
What is the forecast, or price target, for Exicure (XCUR) stock?
Exicure has a consensus price target of $2.00.
What is the current price for Exicure (XCUR)?
The stock price for Exicure (NASDAQ: XCUR) is $11.88 last updated November 21, 2024 at 3:40 PM EST.
Does Exicure (XCUR) pay a dividend?
There are no upcoming dividends for Exicure.
When is Exicure (NASDAQ:XCUR) reporting earnings?
Exicure’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Exicure (XCUR) going to split?
There is no upcoming split for Exicure.
What sector and industry does Exicure (XCUR) operate in?
Exicure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.